MoneyWorks4Me

Brooks Laboratories - Quaterly Results

13 Aug 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 255.12 millions rose by 42.26% from Rs. 179.33 millions.The Total Profit for the quarter ended June 2025 of Rs. 26.50 millions grew from Rs.-2.12 millionsOperating profit for the quarter ended June 2025 rose to 33.43 millions as compared to 3.50 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 255.12 179.33 42.26 255.12 179.33 42.26 825.57 794.86 3.86
Other Income 2.17 0.69 214.49 2.17 0.69 214.49 8.83 9.18 -3.81
PBIDT 33.43 3.50 855.14 33.43 3.50 855.14 58.58 41.73 40.38
Interest 3.01 1.62 85.80 3.01 1.62 85.80 10.28 8.45 21.66
PBDT 30.42 1.88 1518.09 30.42 1.88 1518.09 48.30 33.28 45.13
Depreciation 3.92 4.00 -2.00 3.92 4.00 -2.00 16.02 17.73 -9.64
PBT 26.50 -2.12 -1350.00 26.50 -2.12 -1350.00 32.28 15.55 107.59
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.75 0.26 573.08
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 26.50 -2.12 -1350.00 26.50 -2.12 -1350.00 30.53 15.29 99.67
Equity 294.57 262.47 12.23 294.57 262.47 12.23 294.57 262.47 12.23
PBIDTM(%) 13.10 1.95 571.39 13.10 1.95 571.39 7.10 5.25 35.16
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..